Among higher-cost ICS users in 2003, restricted coverage patients decreased their ICS use relative to unrestricted coverage patients toward the end of 2003, as an increasing number of restricted coverage subjects exceeded the $1,000 benefit cap (Table 2), and these differences remained in 2004 after the loss of brand-name coverage.